Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Clinical Pharmacokinetics|November 17, 2021
Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast CancerC Louwrens Braal, Agnes Jager, Esther Oomen-de Hoop, et al.
Ebiomedicine|March 20, 2024
Hepatotoxicity in patients with non-small cell lung cancer treated with sotorasib after prior immunotherapy: a comprehensive clinical and pharmacokinetic analysisSophie M Ernst, Maaike M Hofman, Tessa E van der Horst, et al.
The Journal of Clinical Investigation|January 17, 2018
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicityAlix F Leblanc, Jason A Sprowl, Paola Alberti, et al.
Breast Cancer Research and Treatment|June 8, 2015
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patientsLisette Binkhorst, Jacqueline S L Kloth, Annelieke S de Wit, et al.
Clinical Pharmacokinetics|June 13, 2023
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer PatientsRuben A G van Eerden, Nikki S IJzerman, Milan van Meekeren, et al.
Scientific Reports|January 26, 2018
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancerBo Gao, Yi Lu, Annemieke J M Nieuweboer, et al.
Breast Cancer Research and Treatment|August 18, 2020
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifenC Louwrens Braal, Koen G A M Hussaarts, Lieke Seuren, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 14, 2023
Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastasesNikki S IJzerman, Wills F Filipe, Peter de Bruijn, et al.
Clinical Pharmacokinetics|July 1, 2024
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic StudyNiels A D Guchelaar, Stefan A J Buck, Leni van Doorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2012
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxelAnne-Joy M de Graan, Cynthia S Lancaster, Amanda Obaidat, et al.
Pageof 9